BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22342424)

  • 21. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
    Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
    Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-130a inhibits HCV replication by restoring the innate immune response.
    Li S; Duan X; Li Y; Liu B; McGilvray I; Chen L
    J Viral Hepat; 2014 Feb; 21(2):121-8. PubMed ID: 24383925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of hepatitis C virus replication by miR-196a using lentiviral vectors.
    Shafaati M; Jamalidoust M; Kargar M; Arefian E; Kafilzadeh F
    Microbiol Immunol; 2021 Apr; 65(4):161-170. PubMed ID: 33470443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microRNAs in hepatitis C virus RNA replication.
    Conrad KD; Niepmann M
    Arch Virol; 2014 May; 159(5):849-62. PubMed ID: 24158346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
    Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
    Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
    J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
    Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
    Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
    J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
    Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
    Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.
    Kan Q; Li D; Yu Z
    J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Replication of hepatitis C virus genome].
    Kato N
    Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
    Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.
    Pan Q; de Ruiter PE; von Eije KJ; Smits R; Kwekkeboom J; Tilanus HW; Berkhout B; Janssen HL; van der Laan LJ
    FEBS Lett; 2011 Apr; 585(7):1025-30. PubMed ID: 21376045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hepatitis C virus replication by pol III-directed overexpression of RNA decoys corresponding to stem-loop structures in the NS5B coding region.
    Zhang J; Yamada O; Sakamoto T; Yoshida H; Araki H; Murata T; Shimotohno K
    Virology; 2005 Nov; 342(2):276-85. PubMed ID: 16139319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
    Mockenhaupt S; Grosse S; Rupp D; Bartenschlager R; Grimm D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4007-16. PubMed ID: 26170322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production.
    Zhou X; Zeng Y; Li J; Guo Y; Fu Y; He J; Sun S; Zhou Y
    Virol J; 2013 Aug; 10():273. PubMed ID: 23987099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of HSVtk gene by endogenous microRNA-122a in liver cell lines as suicide gene therapy.
    Ghanbari M; Saberfar E; Goodarzi Z; Lashini H; Ghanbari S; Karamimanesh M; Baesi K
    Gastroenterol Hepatol Bed Bench; 2017; 10(3):202-207. PubMed ID: 29118936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.